Dyne Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Dyne Therapeutics generated cash of -$188,158,000, which is less than the previous year. Cash used in financing activities reached the amount of $54,322,000 last year. Net change in cash is therefore -$50,525,000.
Cash Flow
| 2014 | -62M | -5.14B | 5.21B |
|---|---|---|---|
| 2015 | 94M | -1.19B | -265M |
| 2016 | 676M | -2.14B | 2.74B |
| 2017 | 585M | -2.75B | -1.29B |
| 2018 | -4.16M | -134K | 12.42M |
| 2019 | -11.83M | -1.64M | 19.98M |
| 2020 | -46.50M | -45.66M | 380.69M |
| 2021 | -119.56M | -137.89M | 157.82M |
| 2022 | -153.64M | 87.20M | 37.39M |
| 2023 | -188.15M | 83.31M | 54.32M |
DYN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 174.46M | 203.51M | 303.15M | 14.63M | 8.12M | -4.29M | 3.83B | 505M | 1.87B | 1.87B |
Operating activities | ||||||||||
Net income | -235.93M | -168.09M | -149.29M | -59.43M | -14.85M | -4.81M | 76M | -1.24B | 50M | -67M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 571K | 1.68M | 1.08M | 700K | 271K | 24K | 867M | 766M | 614M | 292M |
Stock-based compensation expense | 19.97M | 15.17M | 17.54M | 6.59M | 26K | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 19.97M | 15.17M | 17.54M | 6.59M | 26K | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | -47M | 42M | -64M | 161M |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 110M | 154M | -119M | -20M |
Accounts payable | 22.97M | -1.23M | 13.70M | 8.56M | 1.68M | 635K | 46M | 84M | 90M | -131M |
Cash generated by operating activities | -188.15M | -153.64M | -119.56M | -46.50M | -11.83M | -4.16M | 585M | 676M | 94M | -62M |
Investing activities | ||||||||||
Purchases Of Investments | -44.26M | -121.17M | -236.72M | -44.5M | 0 | 0 | 0 | 0 | -250M | 0 |
Investments In Property Plant And Equipment | -729K | -3.06M | -3.61M | -1.16M | -1.64M | -134K | -224M | -326M | -275M | 0 |
Acquisitions Net | 0 | 34K | 8K | 0 | 0 | 0 | -3.31B | 0 | -6.07B | 0 |
Cash generated by investing activities | 83.31M | 87.20M | -137.89M | -45.66M | -1.64M | -134K | -2.75B | -2.14B | -1.19B | -5.14B |
Financing activities | ||||||||||
Common Stock Issued | 52.36M | 36.86M | 157.23M | 246.38M | 19.98M | 7K | 0 | 0 | 0 | 719M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -250M | -1.87B |
Repayments of term debt | 0 | 0 | 0 | -10M | 0 | 0 | 0 | -589M | 0 | -14M |
Cash used in financing activities | 54.32M | 37.39M | 157.82M | 380.69M | 19.98M | 12.42M | -1.29B | 2.74B | -265M | 5.21B |
Net Change In Cash | -50.52M | -29.05M | -99.63M | 288.52M | 6.50M | 12.42M | -3.47B | 1.27B | -1.36B | 0 |
Cash at end of period | 123.94M | 174.46M | 203.51M | 303.15M | 14.63M | 8.12M | 365M | 1.77B | 505M | 1.87B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |